Clinical Trials Browser

OTHER × Neoplasms, Plasma Cell × Bevacizumab × Clear all

NCT00428545 2013-02-12

Bevacizumab and Bortezomib in Patients With Advanced Malignancy

Phase 1 Completed

LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

NCT00482495 2011-05-11

Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell